OVB Share Price Performance
UK£0.011
-0.00 (-28.13%)
Price UK£0.011
Share Pricen/a
No recently updated narratives available.
Ovoca Bio plc, a clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health. Its lead product is Orenetide, a novel synthetic peptide for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.